Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset

There was no significant difference in the cardioversion efficacy or in the risk of adverse events between flecainide and ibutilide in patients with AF of recent onset. In patients without contraindications to both medications, the physician's choice has to be governed by other factors.